375 related articles for article (PubMed ID: 18046226)
21. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration.
Danis RP; Ciulla TA; Pratt LM; Anliker W
Retina; 2000; 20(3):244-50. PubMed ID: 10872928
[TBL] [Abstract][Full Text] [Related]
22. Micropulsed laser photocoagulation and intravitreal triamcinolone acetonide injection for the treatment of retinal angiomatous proliferation.
Roth DB; Scott IU; Gloth JM; Green SN; Yarian DL; Wheatley M
Retina; 2007; 27(9):1201-4. PubMed ID: 18046225
[TBL] [Abstract][Full Text] [Related]
23. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
[TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy with intravitreal application of triamcinolone acetonide in age-related macular degeneration: functional results in 54 patients.
Frimpong-Boateng A; Bunse A; Rüfer F; Roider J
Acta Ophthalmol; 2009 Mar; 87(2):183-7. PubMed ID: 18547278
[TBL] [Abstract][Full Text] [Related]
25. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1.
Regillo CD; Brown DM; Abraham P; Yue H; Ianchulev T; Schneider S; Shams N
Am J Ophthalmol; 2008 Feb; 145(2):239-248. PubMed ID: 18222192
[TBL] [Abstract][Full Text] [Related]
26. Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial.
Gillies MC; Simpson JM; Billson FA; Luo W; Penfold P; Chua W; Mitchell P; Zhu M; Hunyor AB
Arch Ophthalmol; 2004 Mar; 122(3):336-40. PubMed ID: 15006845
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal triamcinolone acetonide injection at the end of vitrectomy for diabetic vitreous hemorrhage: a randomized, clinical trial.
Faghihi H; Taheri A; Farahvash MS; Esfahani MR; Rajabi MT
Retina; 2008 Oct; 28(9):1241-6. PubMed ID: 18626423
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
Jonas JB; Kreissig I; Degenring RF
Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
[TBL] [Abstract][Full Text] [Related]
29. Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER study year 2.
Abraham P; Yue H; Wilson L
Am J Ophthalmol; 2010 Sep; 150(3):315-324.e1. PubMed ID: 20598667
[TBL] [Abstract][Full Text] [Related]
30. Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.
Ruiz-Moreno JM; Montero JA; Amat P; Lugo FL
J Glaucoma; 2009 Jan; 18(1):69-72. PubMed ID: 19142138
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal triamcinolone acetonide injection for the treatment of posterior uveitis.
Ozkiris A
Ocul Immunol Inflamm; 2006 Aug; 14(4):233-8. PubMed ID: 16911985
[TBL] [Abstract][Full Text] [Related]
32. The effect of intravitreal triamcinolone on foveal edema in exudative macular degeneration.
Gillies MC; Larsson J
Am J Ophthalmol; 2007 Jul; 144(1):134-6. PubMed ID: 17601437
[TBL] [Abstract][Full Text] [Related]
33. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration.
Rosenfeld PJ; Heier JS; Hantsbarger G; Shams N
Ophthalmology; 2006 Apr; 113(4):623.e1. PubMed ID: 16581423
[TBL] [Abstract][Full Text] [Related]
34. Cataract progression after intravitreal triamcinolone injection.
Cekiç O; Chang S; Tseng JJ; Akar Y; Barile GR; Schiff WM
Am J Ophthalmol; 2005 Jun; 139(6):993-8. PubMed ID: 15953428
[TBL] [Abstract][Full Text] [Related]
35. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
[TBL] [Abstract][Full Text] [Related]
36. Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion.
Wang L; Song H
Acta Ophthalmol; 2009 May; 87(3):285-9. PubMed ID: 18507724
[TBL] [Abstract][Full Text] [Related]
37. Photodynamic therapy combined with posterior subtenon triamcinolone acetonide injection in the treatment of choroidal neovascularization.
Lee YA; Ho TC; Chen MS; Yang CH; Yang CM
Eye (Lond); 2009 Mar; 23(3):645-51. PubMed ID: 18292791
[TBL] [Abstract][Full Text] [Related]
38. Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.
Kang SW; Park SC; Cho HY; Kang JH
Am J Ophthalmol; 2007 Dec; 144(6):878-885. PubMed ID: 17936715
[TBL] [Abstract][Full Text] [Related]
39. [ITAP - 6-month results of a prospective, randomised phase 3 study for evaluation of the combination therapy of PDT and intravitreal triamcinolone in exudative AMD].
Gamulescu MA; Schubert K; Thormann S; Attaran M; Dueck N; Wiechens B; Spital G; Stroux A; Wachtlin J
Klin Monbl Augenheilkd; 2009 Jan; 226(1):60-5. PubMed ID: 19173165
[TBL] [Abstract][Full Text] [Related]
40. Intravitreal triamcinolone acetonide preceding photodynamic therapy for exudative age-related macular degeneration.
Roth DB; Kulkarni KM; Walsman S; Modi A
Ophthalmic Surg Lasers Imaging; 2009; 40(5):467-71. PubMed ID: 19772270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
